Cargando…

Intravenous Anakinra for Macrophage Activation Syndrome May Hold Lessons for Treatment of Cytokine Storm in the Setting of Coronavirus Disease 2019

Macrophage activation syndrome (MAS) and hemophagocytic lymphohistiocytosis (HLH) are increasingly recognized as being on a continuum of cytokine storm syndromes, with different initiating pathways culminating in cytotoxic dysfunction and uncontrolled activation and proliferation of T lymphocytes an...

Descripción completa

Detalles Bibliográficos
Autor principal:	Wampler Muskardin, Theresa L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231517/ https://www.ncbi.nlm.nih.gov/pubmed/32267072 http://dx.doi.org/10.1002/acr2.11140

Ejemplares similares

Intravenous anakinra for cytokine storm syndromes
por: Jamilloux, Yvan, et al.
Publicado: (2020)

Continuous Intravenous Anakinra Infusion to Calm the Cytokine Storm in Macrophage Activation Syndrome
por: Monteagudo, Luke Adam, et al.
Publicado: (2020)

Intravenous anakinra for cytokine storm syndromes – Authors' reply
por: Mehta, Puja, et al.
Publicado: (2020)

Silencing the cytokine storm: the use of intravenous anakinra in haemophagocytic lymphohistiocytosis or macrophage activation syndrome
por: Mehta, Puja, et al.
Publicado: (2020)

Use of Intravenous Anakinra for Management of Pediatric Cytokine Storm Syndromes at an Academic Medical Center
por: Yang, Lirong, et al.
Publicado: (2023)

Cytokine storm and use of anakinra in a patient with COVID-19
por: Nemchand, Priyanka, et al.
Publicado: (2020)

Early identification of COVID-19 cytokine storm and treatment with anakinra or tocilizumab
por: Langer-Gould, Annette, et al.
Publicado: (2020)

Intravenous administration of anakinra in children with macrophage activation syndrome
por: Phadke, Omkar, et al.
Publicado: (2021)

Etoposide for Cytokine Storm Because of Coronavirus Disease 2019
por: Delgado-López, Pedro David, et al.
Publicado: (2021)

Trypsin may induce cytokine storm in M1 macrophages, resulting in critical coronavirus disease
por: Chen, Hongyu, et al.
Publicado: (2022)

Vitamin intervention for cytokine storm in the patients with coronavirus disease 2019
por: Kang, Jian‐Sheng
Publicado: (2020)

Rapid Response to Cytokine Storm Inhibition Using Anakinra in a Patient With COVID-19 Myocarditis
por: Trpkov, Cvetan, et al.
Publicado: (2020)

The role of a cytokine storm in severe coronavirus disease 2019 in pregnancy
por: Wang, Xiaoping, et al.
Publicado: (2020)

Etoposide as Salvage Therapy for Cytokine Storm Due to Coronavirus Disease 2019
por: Patel, Maulin, et al.
Publicado: (2021)

COVID-19 and cytokine storm syndrome: are there lessons from macrophage activation syndrome?
por: Ombrello, Michael J., et al.
Publicado: (2021)

Prediction of Survival by IL-6 in a Randomized Placebo-Controlled Trial of Anakinra in COVID-19 Cytokine Storm
por: Jackson, Lesley E., et al.
Publicado: (2023)

Comparative Survival Analysis of Immunomodulatory Therapy for Coronavirus Disease 2019 Cytokine Storm
por: Narain, Sonali, et al.
Publicado: (2021)

Immunologic Features in Coronavirus Disease 2019: Functional Exhaustion of T Cells and Cytokine Storm
por: Mahmoudi, Shima, et al.
Publicado: (2020)

Cyclosporine therapy in cytokine storm due to coronavirus disease 2019 (COVID-19)
por: Cure, Erkan, et al.
Publicado: (2020)

Comparison of Anakinra and Tocilizumab in Anticytokine Therapy in the Treatment of Coronavirus Disease-2019
por: Ozkan, Feyza, et al.
Publicado: (2022)

The Consequences of Coronavirus-Induced Cytokine Storm Are Associated With Neurological Diseases, Which May Be Preventable
por: Isacson, Ole
Publicado: (2020)

Cytokine Storm in Coronavirus Disease 2019 and Adult-Onset Still’s Disease: Similarities and Differences
por: Meng, Jianfen, et al.
Publicado: (2021)

Ventricular Fibrillation Storm in Coronavirus 2019
por: Elsaid, Ossama, et al.
Publicado: (2020)

An enlightening role for cytokine storm in coronavirus infection
por: Zhao, Zhongyi, et al.
Publicado: (2021)

Coronavirus disease-2019: A review on the disease exacerbation via cytokine storm and concurrent management
por: Sunkara, Haripriya, et al.
Publicado: (2021)

Anakinra authorized to treat severe coronavirus disease 2019; Sepsis breakthrough or time to reflect?
por: Shapiro, Leland, et al.
Publicado: (2023)

3521 Distinct single cell gene expression in peripheral blood monocytes correlates with treatment response groups to TNF-alpha inhibition in rheumatoid arthritis
por: Muskardin, Theresa Wampler, et al.
Publicado: (2019)

High-dose intravenous vitamin C may help in cytokine storm in severe SARS-CoV-2 infection
por: de Melo, Adriana Françozo, et al.
Publicado: (2020)

Use of Cannabinoids to Treat Acute Respiratory Distress Syndrome and Cytokine Storm Associated with Coronavirus Disease-2019
por: Nagarkatti, Prakash, et al.
Publicado: (2020)

Thymosin Alpha 1 Mitigates Cytokine Storm in Blood Cells From Coronavirus Disease 2019 Patients
por: Matteucci, Claudia, et al.
Publicado: (2020)

86. Intravenous anakinra treatment in a rare case of macrophage activation syndrome presenting as fulminant liver failure
por: Ghuman, Abeer, et al.
Publicado: (2018)

Etoricoxib may inhibit cytokine storm to treat COVID-19
por: Wang, Ruo
Publicado: (2021)

Weathering the COVID-19 storm: Lessons from hematologic cytokine syndromes
por: England, James T., et al.
Publicado: (2021)

Coronavirus disease 2019 (COVID-19): cytokine storms, hyper-inflammatory phenotypes, and acute respiratory distress syndrome
por: Lin, Shi-hui, et al.
Publicado: (2020)

Novel Coronavirus Disease 2019 (COVID-19) and Cytokine Storms for More Effective Treatments from an Inflammatory Pathophysiology
por: Yokota, Shumpei, et al.
Publicado: (2021)

Commentary: Use of Cannabinoids to Treat Acute Respiratory Distress Syndrome and Cytokine Storm Associated With Coronavirus Disease-2019
por: Bifulco, Maurizio, et al.
Publicado: (2021)

From the Oligonucleotide purUUpurU to Cytokine Storm, Elevated Blood Viscosity, and Complications of Coronavirus Disease 2019
por: Sloop, Gregory D, et al.
Publicado: (2022)

Cytokine Storm
por: Fajgenbaum, David C., et al.
Publicado: (2020)

High dose subcutaneous Anakinra to treat acute respiratory distress syndrome secondary to cytokine storm syndrome among severely ill COVID-19 patients
por: Iglesias-Julián, Enrique, et al.
Publicado: (2020)

Treatment of cytokine storm syndrome with IL‐1 receptor antagonist anakinra in a patient with ARDS caused by COVID‐19 infection: A case report
por: Kaps, Leonard, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cls8gq7bannsc63l82sfno7hu9